Search by Drug Name or NDC
NDC 43386-0550-04 Tinidazole 250 mg/1 Details
Tinidazole 250 mg/1
Tinidazole is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals,Inc.. The primary component is TINIDAZOLE.
MedlinePlus Drug Summary
Tinidazole is used to treat trichomoniasis (a sexually transmitted disease that can affect men and women), giardiasis (an infection of the intestine that can cause diarrhea, gas, and stomach cramps), and amebiasis (an infection of the intestine that can cause diarrhea, gas, and stomach cramps and can spread to other organs such as the liver). Tinidazole is also used to treat bacterial vaginosis (an infection caused by an overgrowth of harmful bacteria in the vagina) in women. Tinidazole is in a class of medications called nitroimidazole antimicrobials. It works by killing the organisms that can cause infection. Antibiotics will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 43386-0550-04Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tinidazole
Product Information
| NDC | 43386-0550 |
|---|---|
| Product ID | 43386-550_98a66e10-fb32-46ce-a68b-c21d615f6621 |
| Associated GPIs | 16000053000310 |
| GCN Sequence Number | 057691 |
| GCN Sequence Number Description | tinidazole TABLET 250 MG ORAL |
| HIC3 | W4G |
| HIC3 Description | 2ND GEN. ANAEROBIC ANTIPROTOZOAL-ANTIBACTERIAL |
| GCN | 22867 |
| HICL Sequence Number | 007779 |
| HICL Sequence Number Description | TINIDAZOLE |
| Brand/Generic | Generic |
| Proprietary Name | Tinidazole |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tinidazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | TINIDAZOLE |
| Labeler Name | Lupin Pharmaceuticals,Inc. |
| Pharmaceutical Class | Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202044 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43386-0550-04 (43386055004)
| NDC Package Code | 43386-550-04 |
|---|---|
| Billing NDC | 43386055004 |
| Package | 40 TABLET in 1 BOTTLE (43386-550-04) |
| Marketing Start Date | 2012-04-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |